In CKD, reduced glomerular filtration of phosphate is initially counteracted by the phosphaturic hormones fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH), before these compensatory mechanisms are overwhelmed and hyperphosphatemia ensues (5). This evidence concerns the gene FGF23 and hyperphosphatemia.